Regulatory compliance in the beauty industry has become a strategic pillar for many brands and manufacturers. It is shaping everything from formulation and supply chain design to brand storytelling and speed to market. As brands scale across borders, the complexity of navigating divergent regulatory frameworks has quietly become one of the most decisive forces in determining whether a product succeeds globally or stalls at the border.
For manufacturers operating at the center of this ecosystem, compliance has moved from simply being about meeting requirements. It is about architecting systems that anticipate them. “Regulatory strategy has to start at the same moment as formulation intent,” Anne-Charlotte Lamboley, Regulatory Affairs Manager at manufacturing hub Capsum, said to BeautyMatter. “At Capsum, regulatory is involved very early because once a formula exists, many strategic options are already closed.”
The challenge facing global manufacturers is not just multiplicity but misalignment. Regulatory frameworks across the EU, US, China, the Association of Southeast Asian Nations (ASEAN), and the Gulf Cooperation Council (GCC) markets differ not only in scope but in philosophy, including precautionary principles and post-market surveillance models.
Capsum’s response is to build from the strictest baseline. “The EU remains the gold standard globally,” Lamboley said. “It is one of the most demanding regulatory systems in terms of consumer safety, environmental protection, ingredient controls, and claims substantiation. By building from EU, US, and China compliance as a baseline, we cover a significant part of the world.”
This “top-down” approach shows a wider industry shift that, rather than retrofitting products for new markets, manufacturers are increasingly designing formulas to travel from inception. At Hunter Amenities International, a supplier of hotel amenities and guest supplies, that philosophy is embedded directly into R&D. “All the R&D formula work [we do] is directed to be globally compliant formulas,” CEO and founder John Hunter told BeautyMatter. “All the brands we bring to market will be sold across the globe, and thus it makes sense to have one formula, for ease of stability/compatibility work and formula transfer among our various entities in different regions.”
For early-stage brands, that complexity is often underestimated. “Many first-time entrepreneurs come from other sectors and assume regulatory approval is a final checkpoint rather than a continuous process,” Lamboley explained. “In reality, regulatory readiness impacts formulation choices, timelines, artwork development, and even commercial strategy.”
This misconception can be particularly pronounced among indie brands, where creative vision often outpaces technical infrastructure. According to Hunter, the entrepreneurs behind the brand are very creative but many lack formulating experience, thus are not well-versed in the complexity.
The implications go beyond formulation. One of the most overlooked and time-intensive aspects of compliance lies in packaging and communication. “Labels, claims, INCI [International Nomenclature of Cosmetic Ingredients] lists, warnings, languages, formatting—each of these elements requires regulatory review, and they are more time consuming than many founders expect,” Lamboley said. “Compliance is not only about what is in the bottle; it is also about everything that surrounds it.”
Regulatory change is accelerating, driven by evolving scientific research, environmental concerns, and shifting consumer expectations. For manufacturers, this translates into a near-constant state of adaptation. “Yes, reformulation cycles are increasing, largely due to regulatory updates driven by safety reassessments, environmental considerations, or evolving scientific data,” Lamboley noted.
But the operational impact of these changes depends heavily on foresight. “Because we monitor regulatory discussions throughout the year, we can anticipate changes in advance. Anticipation is the difference between reactive reformulation and controlled evolution,” she continued. Without that anticipation, the pressure on resources can be significant. “It seems there is a new banned substance somewhere in the world on a weekly basis that causes an increasing demand on our resources,” Hunter added.
Behind the scenes, though, compliance is becoming an infrastructure play. Capsum, for example, relies on a robust internal regulatory database that centralizes ingredient statuses, conditions of use, upcoming amendments, and historical trends, combined with upstream monitoring of regulatory discussions long before texts are published.
This level of systemization allows manufacturers to do more than comply. It allows them to advise. “Our role is not to complicate development but to provide clear guidance early so that the final product moves smoothly and efficiently to market,” said Lamboley.
At Hunter Amenities, internal expertise plays a similar role in simplifying complexity for brand partners. “This is one of Hunter’s strengths as a development partner, making complex issues easier for our partners,” said Hunter. As regulatory demands grow, these capabilities are becoming a defining factor in partner selection.
For brands with global ambitions, the real question is when compliance matters. “If global expansion is the objective, compliance thinking should start immediately,” Lamboley said. “The earlier a brand thinks globally, the fewer compromises it will face later.”
The warning signs of a non-scalable strategy are equally clear. “The absence of defined regulatory frameworks or ingredient constraints, no dedicated person responsible for compliance, or an undefined retail strategy often reflects a lack of vision rather than a lack of resources.”
Hunter pointed to a more practical inflection point. “Any indie brand that is considering global expansion will have to have a formula review as part of its plans, as many formulas would not be acceptable in the EU, for instance.” In other words, scalability is not an outcome but a design choice.
Also, as compliance becomes more complex, the manufacturer's role is evolving from executor to strategic advisor. For Lamboley, this begins with integration: regulatory, R&D, and quality teams working in tandem, alongside alignment with certifications, retailer standards, and brand-specific constraints.
For Hunter, it is about transparency and trust. “Ask what internal capabilities and past experience the team has. At Hunter, we are fortunate to have an amazing team that our partners can rely on.” Lamboley reinforced the importance of visibility into the process. “A manufacturer should not be a black box. Brands should look for a partner, not just a producer. When expectations are clear on both sides, efficiency increases, relationships remain smooth, and both parties ultimately win.”
This causes a fundamental shift in how compliance is understood across the beauty value chain. No longer a final checkpoint, it is now a system that informs formulation, supply chain decisions, brand positioning, and long-term growth. Manufacturers that can anticipate regulatory change, engineer globally viable formulas, and guide brands through complexity are indispensable enablers of expansion. In a market where crossing borders is both an opportunity and a risk, that capability is fast becoming a defining competitive edge.